期刊
RHEUMATOLOGY
卷 49, 期 11, 页码 2217-2219出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq249a
关键词
Rheumatoid arthritis; British Society for Rheumatology; Guidelines; Anti-TNF therapies; Drug safety; Adverse event; Infliximab; Etanercept; Adalimumab